Drug Patent Expirations in July 2009 *Drugs may be covered by multiple patents Tradename Applicant Generic Name Patent Number Patent Expiration LEVULAN Dusa aminolevulinic acid hydrochloride 5,422,093 Jul 28, 2009 LEVULAN Dusa aminolevulinic acid hydrochloride 6,710,066 Jul 28, 2009 OPTIMARK Mallinckrodt gadoversetamide 5,130,120 Jul 14, 2009 OPTIMARK Mallinckrodt gadoversetamide 5,137,711 Jul 14, 2009 OPTIMARK IN PLASTIC CONTAINER Mallinckrodt gadoversetamide 5,130,120 Jul 14, 2009 OPTIMARK IN PLASTIC CONTAINER Mallinckrodt gadoversetamide 5,137,711 Jul 14, 2009 PAXIL CR Glaxosmithkline paroxetine hydrochloride 5,789,449 Jul 6, 2009 TRITEC Glaxosmithkline ranitidine bismuth citrate 5,008,256 Jul 17, 2009
Instant Access with secure payment processing: $235 / One Month $975 / One Year Need an invoice? Group rate? Contact admin@DrugPatentWatch.com

Your source for pharmaceutical industry intelligence

	Subscribe for free drug patent expiration updates Enter your email address: Also available in a RSS feed

[ Home | Free Patent Expiration Bulletin | Affiliate Program | Contact ]
Follow DrugPatentWatch on Twitter
Bookmark This Site